Dunn Edmund

Principal Accounting OfficerMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Mar 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$465K
Net Open-Market Flow
-$465K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)536$17.50$9K23K
Mar 2, 2026Option exercise(M)536$13.41$7K23K
Feb 27, 2026Option exercise(M)25K$13.41$337K48K
Feb 27, 2026Sell(S)25K$18.10$455K23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)536$00
Feb 27, 2026Option exercise(M)25K$0536

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-085677) within minutes of acceptance. Every field above traces to the original document. Verify it directly: